Investors

TSO₃ has developed a sterilization process that responds to market demand. Using ozone, a powerful microbicidal agent naturally produced in the atmosphere, it offers all the advantages of autoclave sterilization while permitting fast, cost-effective sterilization at low temperature, without compromising the safety of the users or the protection of the environment. This is a genuine technological breakthrough whose characteristics are unique in the world for low-temperature sterilization.

The first product based on this technological platform is the 125L Ozone Sterilizer - named after its 125-litre/4.3-cubic-foot capacity - first intended for hospital sterilization units.

Video Presentation of our Technology

In 2003, TSO₃ received clearance from both Health Canada and the FDA to market the sterilizer to health care facilities in Canada and the United States respectively. TSO₃ has undertaken the sale of its first product early 2006.